An unusual Staphylococcus saccharolyticus spondylodiscitis post kyphoplasty: a case report.
Amoxicillin
/ administration & dosage
Anti-Bacterial Agents
/ administration & dosage
Coagulase
/ metabolism
Cross Infection
/ diagnosis
Discitis
/ diagnostic imaging
Humans
Kyphoplasty
/ adverse effects
Magnetic Resonance Imaging
Male
Middle Aged
Postoperative Complications
/ diagnosis
Staphylococcal Infections
/ diagnosis
Staphylococcus
/ enzymology
Thoracic Vertebrae
/ diagnostic imaging
Treatment Outcome
Case report
Healthcare-associated infection
Kyphoplasty
Spondylodiscitis
Staphylococcus saccharolyticus
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
23 Jul 2020
23 Jul 2020
Historique:
received:
17
03
2020
accepted:
16
07
2020
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
22
8
2020
Statut:
epublish
Résumé
Staphylococcus saccharolyticus is a rarely encountered coagulase-negative, which grows slowly and its strictly anaerobic staphylococcus from the skin. It is usually considered a contaminant, but some rare reports have described deep-seated infections. Virulence factors remain poorly known, although, genomic analysis highlights pathogenic potential. We report a case of Staphylococcus saccharolyticus spondylodiscitis that followed kyphoplasty, a procedure associated with a low rate but possible severe infectious complication (0.46%), and have reviewed the literature. This case specifically stresses the risk of healthcare-associated S. saccharolyticus infection in high-risk patients (those with a history of alcoholism and heavy smoking). S. saccharolyticus infection is difficult to diagnose due to microbiological characteristics of this bacterium; it requires timely treatment, and improved infection control procedure should be encouraged for high-risk patients.
Sections du résumé
BACKGROUND
BACKGROUND
Staphylococcus saccharolyticus is a rarely encountered coagulase-negative, which grows slowly and its strictly anaerobic staphylococcus from the skin. It is usually considered a contaminant, but some rare reports have described deep-seated infections. Virulence factors remain poorly known, although, genomic analysis highlights pathogenic potential.
CASE PRESENTATION
METHODS
We report a case of Staphylococcus saccharolyticus spondylodiscitis that followed kyphoplasty, a procedure associated with a low rate but possible severe infectious complication (0.46%), and have reviewed the literature. This case specifically stresses the risk of healthcare-associated S. saccharolyticus infection in high-risk patients (those with a history of alcoholism and heavy smoking).
CONCLUSION
CONCLUSIONS
S. saccharolyticus infection is difficult to diagnose due to microbiological characteristics of this bacterium; it requires timely treatment, and improved infection control procedure should be encouraged for high-risk patients.
Identifiants
pubmed: 32703263
doi: 10.1186/s12879-020-05263-5
pii: 10.1186/s12879-020-05263-5
pmc: PMC7379344
doi:
Substances chimiques
Anti-Bacterial Agents
0
Coagulase
0
Amoxicillin
804826J2HU
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
539Références
BMC Infect Dis. 2018 Nov 12;18(1):555
pubmed: 30419832
J Med Case Rep. 2011 Mar 13;5:101
pubmed: 21396128
J Clin Microbiol. 1978 Mar;7(3):261-4
pubmed: 649761
Joint Bone Spine. 2005 Jan;72(1):91-3
pubmed: 15681259
J Clin Microbiol. 1990 Dec;28(12):2818-9
pubmed: 2280017
Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1161-3
pubmed: 25912574
Int J Infect Dis. 2009 Mar;13(2):e43-6
pubmed: 18815064
Clin Infect Dis. 1996 Apr;22(4):722-3
pubmed: 8729221
Case Rep Infect Dis. 2017;2017:3713212
pubmed: 29109878
J Biomater Appl. 2011 Sep;26(3):277-92
pubmed: 20566659
Orthopedics. 2009 Jan;32(1):60
pubmed: 19226022
Front Microbiol. 2019 Mar 12;10:478
pubmed: 30915059
Spine J. 2013 Dec;13(12):1809-17
pubmed: 23880354
Front Microbiol. 2015 Jan 13;5:787
pubmed: 25628618
J R Soc Interface. 2013 Jan 6;10(78):20120647
pubmed: 23097502